The New Diseases and the Old Agents

The Veterinarian Perspective
  • Yolanda Vaz
  • Telmo Nunes


This is a changing World. Man is at the origin of many changes with impact in animal and human health. Among them we can refer the development of fast round-the-World transport, the industrialization and its environmental effects, the increasing complexity of the food chain, the urbanization and the technological development, allowing manipulation of disease agents and creating the present information centered society. These changes have an influence on the re-emergence of animal and human diseases which result, among other reasons, from the microbial adaptation and change, the infection of new populations, the use of new means of dispersion, the expansion of vectors, or even from the improved capacity of diagnosis and better community awareness. In this work some of these aspects are discussed and research contribution of the Faculty of Veterinary Medicine of Lisbon is briefly referred.

Key words

Re-emerging diseases zoonosis research 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    World Tourism Organization 2005. Scholar
  2. 2.
    WTO 2005. Scholar
  3. 3.
    DEFRA. “Origin of the UK Foot and Mouth Disease epidemic in 2001”. June 2002. Scholar
  4. 4.
    Meredith M. “Meat Smuggling-Risk Assessment and Control”. AASV News Archive2nd April 2003. Scholar
  5. 5.
    DEFRA. Foot and Mouth Disease. Scholar
  6. 6.
    Meredith M. “Exotic Disease Responses Re-assessed”. AASV News Archive, 20th December 2002. Scholar
  7. 7.
    Mounts AW, Kwong H, Izurieta HS, Ho Y, Au T, Lee M, Buxton Bridges C, William SW, Mak HK, Katz JM, Thompson WW, Cox NJ, Fukuda K. “Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997”. Journal of Infectious Diseases, 180(2), pp. 505–508, August 1999.CrossRefGoogle Scholar
  8. 8.
    WHO “Responding to the avian influenza pandemic threat — Recommended strategic actions”. Communicable Diseases Surveillance and Response. Global Influenza Program. WHO/CDS/CSR/GIP/2005.8.Google Scholar
  9. 9.
    WHO “Food safety-Enterohaemorrhagic Escherichia coli infection, Japan”. Weekly Epidemiological Record, 35, pp. 267–268, 1996.Google Scholar
  10. 10.
    WHO “Food safety-Outbreak of Escherichia coli O157 infection, United Kingdom (Scotland)”. Weekly Epidemiological Record, 50, pp. 384, 1996.Google Scholar
  11. 11.
    Ziese T, Anderson Y, de Jong B, Löfdahl S, Ramberg M. “Outbreak of Escherichia coli O157 in Sweden”. Euro Surveillance, 1(1), pp. 2–3, 1996.Google Scholar
  12. 12.
    FSA. Food Safety Agency Wales. Response to E.coli report. Jan 2006. Scholar
  13. 13.
    Buckley-Golder D. “Compilation of EU Dioxin Exposure and Health data. Summary Report 1999”. Scholar
  14. 14.
    Bernard A, Fierens S. “The Belgian PCB/dioxin incident: a critical review of health risks evaluations.” International Journal of Toxicology, 21(5), pp.333–340. Sep–Oct 2002CrossRefGoogle Scholar
  15. 15.
    DGV. Resíduos de Nitrofuranos em Portugal — Relatório Final 2003. Scholar
  16. 16.
    Patz JA, McGeehin MA, Bernard SM, Ebi KL, Epstein PR, Grambsch A, Gubler DJ, Reiter P, Romieu I, Rose JB, Samet JM and Trtanj J. “The Potential Health Impacts of Climate Variability and Change for the United States: Executive Summary of the Report of the Health Sector of the U.S. National Assessment”. Environmental Health Perspectives, 108(4) pp. 301–304, April 2002Google Scholar
  17. 17.
    WHO “Yellow Fever: a current Threat”. Scholar
  18. 18.
    WHO “The Yellow Fever situation in Africa and South America in 2004”. Weekly Epidemiological Record, 80(29), pp. 250–256, July 2005. Scholar
  19. 19.
    U.N. Human Development Reports Statistics. Scholar
  20. 20.
    DGV. Official Veterinary Authority of Portugal — Annual reports on BSE 2005.Google Scholar
  21. 21.
    Benestad SL, Sarradin P, Thu B, Schonheit J, Tranulis MA, Bratberg B. “Cases of scrapie with unusual features in Norway and designation of a new type, Nor98”. Veterinary Record, 153(7), pp.202–208, August 2003.CrossRefGoogle Scholar
  22. 22.
    OIE Working Group for Wildlife Diseases. Scholar
  23. 23.
    FBI Press Release, 20 December 2001. Scholar
  24. 24.
    Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Friedlander AM, Hauer J, MacDade J, Osterholm MT, O’Toole T, Parker G, Perl TM, Russel PK, Tonat K. “Anthrax as a Biological Weapon — Medical and Public Health Management”. Journal of American Medical Association, 281(18), pp. 1735–1745, May 1999.CrossRefGoogle Scholar
  25. 25.
    EMEA “Antibiotic resistance in the EU associated with therapeutic use of veterinary medicines”. Report on the qualitative risk assessment by the Committee of Veterinary Medical Products. July 1999.Google Scholar
  26. 26.
    Van de Venter T. “Prospects for the future: emerging problems — chemical/biological”. Conference on International Food Trade Beyond 2000: Science-Based Decisions, Harmonization, Equivalence and Mutual Recognition. Melbourne, Australia, 11–15 October 1999.Google Scholar
  27. 27.
    Gibbs EP. “Emerging zoonotic epidemics in the interconnected global community”. Veterinary Record, 157, pp.673–679, November 2005.Google Scholar
  28. 28.
    Marano N, Arguin P, Pappaioanou M, King L. “Role of Multisector Partnership in Controlling Emerging Zoonotic Diseases”. Emerging Infectious Diseases, 11(12), pp. 1813–1814, December 2005.Google Scholar
  29. 29.
    Wildlife Conservation Society. “The Manhattan Principles on “One World — One Health”. Scholar

Copyright information

© Springer 2007

Authors and Affiliations

  • Yolanda Vaz
    • 1
  • Telmo Nunes
    • 1
  1. 1.Faculdade de Medicina VeterináriaUniversidade Técnica de LisboaLisboaPortugal

Personalised recommendations